Thomsen M, Ryder L P, Svejgaard A
Scand J Immunol. 1976 Jun;Suppl 5:157-74. doi: 10.1111/j.1365-3083.1976.tb03866.x.
MLC typing of random individuals can be performed using a panel of inactivated HLA-D homozygous cells. Eight different HLA-D specificities are now internationally accepted. The evaluation of the results must take into account both the general responding capacity of the cell to be typed and the general stimulating capacity of the typing cells. An evaluation based on the 75th percentile is discussed in detail and some pitfalls are mentioned. Furthermore a description is given of primed lymphocyte typing (PLT), where cells primed in ordinary MLC cultures to one HLA-D determinant have the ability to respond in an accelerated way to similar HLA-D antigens when re-exposed to such cells in secondary cultures. In our experiments, an excellent correlation is found between these two ways of MLC typing provided that the cells used for priming are well characterized (i.e. HLA-D homozygous cells). Finally, some clinical applications of MLC typing are described, especially in connection with transplantation and association between HLA and various diseases.
可使用一组经灭活的HLA - D纯合细胞对随机个体进行混合淋巴细胞培养(MLC)分型。目前国际上已认可八种不同的HLA - D特异性。对结果的评估必须同时考虑待分型细胞的总体反应能力和分型细胞的总体刺激能力。详细讨论了基于第75百分位数的评估方法,并提及了一些陷阱。此外,还介绍了致敏淋巴细胞分型(PLT),即在普通MLC培养中被致敏至一种HLA - D决定簇的细胞,当在二次培养中再次接触此类细胞时,有能力以加速方式对相似的HLA - D抗原作出反应。在我们的实验中,只要用于致敏的细胞特征明确(即HLA - D纯合细胞),这两种MLC分型方法之间就会发现极好的相关性。最后,描述了MLC分型的一些临床应用,特别是与移植以及HLA与各种疾病之间的关联有关的应用。